异基因移植后急性髓系白血病复发中重编程失败的移植物抗白血病免疫的研究进展
Progress in reprogramming failed graft-versus-leukemia immunity in acute myeloid leukemia relapse after allogeneic transplantation.
81.4分
★★★★☆
站内排序·非疗效
FRONTIER PAPERS
Progress in reprogramming failed graft-versus-leukemia immunity in acute myeloid leukemia relapse after allogeneic transplantation.
CAR-T and CAR-NK cell therapies in AML: breaking barriers and charting the future.
共 2 条
MEMBER ACCOUNT
登录成功会直接打开下一页。